Eli Lilly's Alzheimer's treatment approved in China
(Reuters) - China's medical regulator has approved Eli Lilly (NYSE:LLY)'s treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen...
(Reuters) - China's medical regulator has approved Eli Lilly (NYSE:LLY)'s treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen...
-- LKQ Corporation (NASDAQ:LKQ), a leading name in the automotive aftermarket is emerging as a compelling play for 2025, thanks to a strategic shift toward...
WASHINGTON (Reuters) - The Republican chairman of the U.S. House of Representatives Committee on Homeland Security said on Tuesday he expects to see the revival of a Justice...
By Sneha Kumar and Rishav Chatterjee (Reuters) - Australian discretionary retailers could benefit from expected interest rate cuts in 2025, analysts say, as shoppers loosen their...
By Makiko Yamazaki TOKYO (Reuters) -Japan's exports rose faster than expected in November, data showed on Wednesday, helped by a weaker yen and solid global demand although...
- Litecoin was trading at $127.409 by 20:25 (01:25 GMT) on the Index on Wednesday, up 10.07% on the day. It was the largest one-day percentage gain...
-- Australia's Insignia Financial has rejected a A$2.67 billion ($1.69 billion) takeover bid from Bain Capital, saying the offer does not provide fair value to its...
SYDNEY (Reuters) -Australia's government on Wednesday trimmed its likely budget deficit for the current fiscal year, but flagged bigger shortfalls ahead due to "unavoidable...
By Brigid Riley TOKYO (Reuters) - The U.S. dollar held steady against the yen and other major rivals on Wednesday as investors waited to see whether the Federal Reserve will...
By Jarrett Renshaw, Rachael Levy and Chris Kirkham (Reuters) - The Trump transition team wants the incoming administration to drop a car-crash reporting requirement opposed by...